Foreword. Contributors. 1. The epidemiology of cardiovascular disease. 2. Using guidelines as a framework for cardiovascular risk management: comparison of international recommendations. 3. Identifying high-risk patients. 4. Moderate- to low-risk patients: management recommendations. 5. High-risk patients: management recommendations. 6. Type 2 diabetes and metabolic syndrome patients: management recommendations for reducing cardiovascular risk. 7. Lifestyle changes to reduce cardiovascular risk. 8. Pharmacotherapy: improving the lipid profile. 9. Pharmacotherapy: lowering blood pressure. 10. Pharmacotherapy: lowering blood glucose. 11. Long-term management of cardiovascular disease. 12. Managing cardiovascular risk in the future. Appendix. Index.
Prof Richard Hobbs , Professor and Head of Primary Care and General Practice, Primary Care , University of Birmingham. Prof Bruce Arroll , Dept of General Practice and Primary Care, University of Auckland, Auckland, New Zealand. The chapter authors are members of a group of global experts on metabolic and vascular disease called the Future Forum. This group brings together specialists and primary care physicians to debate current issues via a closed website and at twice yearly conferences.
"An updated text, which has the merit of taking stock of the situation in a field, the management of cardiovascular risk, where the fast and sudden classification of the patient is essential . . . In conclusion, the work is properly addressed to all those who wish to have an overview of the management of patients at risk for cardiovascular disease, including nuclear physicians involved in nuclear cardiology." (Eur J Nucl Med Mol Imaging, 2010) "This is an extremely valuable book for practicing physicians and researchers of cardiovascular disease. I highly recommend it for every medical library.? (Doody's Reviews, May 2009)